The Friday Five for February 28, 2020:
- Coronavirus: Continuing Coverage
- Apple Heartline Study
- Medicare-for-all Explainer
- Salesforce acquires Vlocity
- Seema Verma speaks at NAHU Capitol Conference 2020
Mentioned in this episode:
Medicare and Medicaid Programs: Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescriptions Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly
More episodes you’ll like:
Master your final expense sales pitch with these steps. We discuss how to help you bring up the subject of final expense with confidence and convert more prospects into clients.
Build a portfolio that shows clients you care. Cancer, heart attack, and stroke insurance plans provide coverage and peace of mind when your clients need it most.
Thinking about partnering with a field marketing organization? Wondering how you can tell the good from the bad? Our top 10 list outlines what you need to know before you partner with an FMO.
Stay HIPAA compliant with the Agent Survival Guide Podcast! Find out what you’re responsible for under HIPAA regulations.
You've worked hard to create and grow your insurance business — but how do you protect your investment? Even insurance agents need protection. In this episode, we make the case for errors and omissions (E&O) insurance.
The latest from Ritter’s Blog:
Do you question the value of cancer, heart attack and stroke plans? Why would (or should!) anyone buy a policy that’s so specific? We can think of a few good reasons...(read more)
The standard monthly Part B premium cost for beneficiaries in 2020 is $144.60. Wouldn’t it be nice if your clients could get some of that money back? Good news, this is a possibility...(read more)
Which products should a Medicare sales agent sell outside of the Annual Enrollment Period to keep earning commissions? We’ve got the top five additional plan types that should be a part of an agent’s portfolio during the... (read more)
Subscribe & Follow:
Connect on social: